International Peer-Reviewed JournalOpen AccessISSN 2456-8880
irejournals@gmail.com+91-7433024337

Home / Current Issue / Paper 1718195

1718195 Vol 9 · Issue 11 Download Paper

Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review

Shikha Pandey Prashant Kumar Singh Debabrata Lahiry

Subject area: Biological & Medical Sciences  ·  Area of research: Pharmacological Profiling

DOI: https://doi.org/10.64388/IREV9I11-1718195

Abstract

The rapid escalation of antimicrobial resistance and the associated decline in the effectiveness of conventional antibiotics have intensified the global search for alternative therapeutic agents derived from natural sources. Medicinal plants continue to serve as valuable reservoirs of structurally diverse bioactive compounds with broad pharmacological potential. Eurycoma longifolia Jack (family: Simaroubaceae), commonly known as Tongkat Ali, is a traditional medicinal plant indigenous to Southeast Asia and widely used for the treatment of fever, infections, malaria, fatigue, and sexual dysfunction. Although the aphrodisiac and antimalarial properties of E. longifolia are well established, increasing experimental evidence suggests significant antimicrobial activity against a variety of bacterial and fungal pathogens. This review critically compiles and evaluates published literature on the phytochemical composition, pharmacological properties, and in-vitro antimicrobial activity of Eurycoma longifolia. Emphasis is placed on studies conducted by different researchers, extraction strategies, experimental methodologies, antimicrobial efficacy against Gram-positive and Gram-negative bacteria as well as pathogenic fungi, and proposed mechanisms of action. Challenges related to standardization, reproducibility, and clinical translation are discussed. Overall, E. longifolia emerges as a promising natural source of antimicrobial agents with potential applications in combating drug-resistant infections.

Keywords

Eurycoma Longifolia, Tongkat Ali, Antimicrobial Activity, Phytochemistry, Quassinoids, Medicinal Plants

References

[1] Rahman MA, Abdullah R, Karim MS, Latif FA. Antibacterial properties of Eurycoma longifolia methanolic extracts against pathogenic bacteria. J Ethnopharmacol. 2023;312:116434.

[2] Nguyen HT, Tran DN, Pham TN, Le MH. Antifungal activity of quassinoids isolated from Eurycoma longifolia against Candida albicans. Phytomedicine. 2023;112:154675.

[3] Lim SH, Wong CF, Tan JW, Goh BH. Comparative antioxidant and antimicrobial activity of aqueous and ethanolic extracts of Eurycoma longifolia. BMC Complement Med Ther. 2022;22(1):167-176.

[4] Sundaram S, Chinnaiyan P, Kumar A. Synergistic antibacterial activity of Eurycoma longifolia extracts with ciprofloxacin against multidrug-resistant pathogens. Front Microbiol. 2022;13:956732.

[5] Husin F, Ghazali AR, Mokhtar NM, Yusoff N. Pharmacological profiling and antimicrobial activity of standardized Eurycoma longifolia extracts. J Appl Pharm Sci. 2021;11(5):98-107.

[6] Tan YH, Low YL, Lee WS. Antibacterial activity of canthin-6-one alkaloids from Eurycoma longifolia. Nat Prod Res. 2021;35(18):3021-3029.

[7] Ong YS, Ng HM, Lim YY. In vitro and in silico evaluation of eurycomanone as an antimicrobial and antimalarial agent. Molecules. 2020;25(14):3329.

[8] Zakaria ZA, Hassan MH, Ismail Z. Antibacterial activity of Eurycoma longifolia against methicillin-resistant Staphylococcus aureus. Trop Biomed. 2020;37(3):515-523.

[9] Low BS, Das PK, Chan KL. Antimicrobial and antioxidant effects of Eurycoma longifolia extracts in rodent models. Evid Based Complement Alternat Med. 2019;2019:8745326.

[10] Kumar S, Rajan R, Kumar A. Bactericidal activity of quassinoid fractions from Eurycoma longifolia roots. Asian J Pharm Clin Res. 2019;12(7):145-152.

[11] Mohd I, Ali R, Zainal Z, Ahmad N. Comparative antimicrobial activity of aqueous and ethanolic extracts of Eurycoma longifolia. Pharmacogn J. 2018;10(5):865-872.

[12] Joseph P, Rajan T, Samuel J. Antifungal potential of Eurycoma longifolia extracts against Candida species. Mycoses. 2018;61(10):761-768.

[13] Ismail Z, Asmawi MZ, Ghazali AR. Immunomodulatory and antimicrobial effects of Eurycoma longifolia extracts. J Ethnopharmacol. 2017;206:245-252.

[14] Ang HH, Lee KL, Kiyoshi M. A review on the pharmacological properties of Eurycoma longifolia with emphasis on antimicrobial activities. Phytother Res. 2016;30(12):1785-1794.

[15] Bhat R, Karim AA. Tongkat Ali (Eurycoma longifolia Jack): Pioneering antimicrobial screening of its root extracts. Fitoterapia. 2015;105:155-161.

How to cite this paper

Shikha Pandey, Prashant Kumar Singh, Debabrata Lahiry "Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review" Iconic Research And Engineering Journals Volume 9 Issue 11 2026 Page 3296-3299 https://doi.org/10.64388/IREV9I11-1718195
Shikha Pandey, Prashant Kumar Singh, Debabrata Lahiry "Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review" Iconic Research And Engineering Journals, vol. 9, no. 11, May. 2026, doi: https://doi.org/10.64388/IREV9I11-1718195
Shikha Pandey, Prashant Kumar Singh, Debabrata Lahiry (2026). Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review. Iconic Research And Engineering Journals, 9(11). doi: https://doi.org/10.64388/IREV9I11-1718195
Shikha Pandey, Prashant Kumar Singh, Debabrata Lahiry "Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review" Iconic Research And Engineering Journals, vol. 9, no. 11, May. 2026. Crossref, https://doi.org/10.64388/IREV9I11-1718195
@article{1718195,
      author = {Shikha Pandey, Prashant Kumar Singh, Debabrata Lahiry},
      title = {Pharmacological Profiling and In-Vitro Antimicrobial Activity of Eurycoma Longifolia Jack (Tongkat Ali): A Comprehensive Review},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {9},
      number = {11},
      pages = {3296-3299},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718195.pdf},
      abstract = {The rapid escalation of antimicrobial resistance and the associated decline in the effectiveness of conventional antibiotics have intensified the global search for alternative therapeutic agents derived from natural sources. Medicinal plants continue to serve as valuable reservoirs of structurally diverse bioactive compounds with broad pharmacological potential. Eurycoma longifolia Jack (family: Simaroubaceae), commonly known as Tongkat Ali, is a traditional medicinal plant indigenous to Southeast Asia and widely used for the treatment of fever, infections, malaria, fatigue, and sexual dysfunction. Although the aphrodisiac and antimalarial properties of E. longifolia are well established, increasing experimental evidence suggests significant antimicrobial activity against a variety of bacterial and fungal pathogens. This review critically compiles and evaluates published literature on the phytochemical composition, pharmacological properties, and in-vitro antimicrobial activity of Eurycoma longifolia. Emphasis is placed on studies conducted by different researchers, extraction strategies, experimental methodologies, antimicrobial efficacy against Gram-positive and Gram-negative bacteria as well as pathogenic fungi, and proposed mechanisms of action. Challenges related to standardization, reproducibility, and clinical translation are discussed. Overall, E. longifolia emerges as a promising natural source of antimicrobial agents with potential applications in combating drug-resistant infections.},
      keywords = {Eurycoma Longifolia, Tongkat Ali, Antimicrobial Activity, Phytochemistry, Quassinoids, Medicinal Plants},
      month = {May},
      doi = {https://doi.org/10.64388/IREV9I11-1718195}
  }